Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hoth Therapeutics Inc
HOTH
Healthcare
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s...
or other neuroinflammatory diseases (HT-ALZ). It also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for acne as well as inflammatory bowel diseases (HT-003). Its development products include HT-001, HT-KIT, HT-ALZ, and HT-TBI. Its BioLexa Platform is a proprietary, patented, drug compound platform for the treatment of eczema. The Company also has interests in certain other assets being developed by third parties including a treatment for patients with lupus.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:HOTH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 27, 2024 2:00pm
New Press Release - Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
NEW YORK, March 27, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,500,000 shares of...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 27, 2024 8:28am
New Press Release - Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Merveille.ai Files Patent for Obesity Treatment, Begins Preparatory Steps for Clinical Trials, Joins Nvidia Developer ProgramNEW YORK, March 27, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, is excited to announce a significant...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 19, 2024 11:37am
HOTH...vols have all but dried up
if you were a gambler...might take a position here at $1.27 Not me...going skiing ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 19, 2024 11:13am
HOTH....Green to Red move.....
Wait for it
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 19, 2024 11:03am
HOTH...you've all been had...again !
Same chit.....different pile
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 19, 2024 11:01am
HOTH....almost 18 million shares have traded....
and all u get is 20 cents???? Whats wrong with this picture?????
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 19, 2024 10:59am
RE:HOTH.....Oh boy...heres the big bidder
Big Bids sink ships.... I always say ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 19, 2024 10:55am
HOTH.....Oh boy...heres the big bidder
That is the kiss o death Hurry up and dye
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 19, 2024 10:46am
HOTH...might just be done for the day ; )
No position
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 19, 2024 9:40am
RE:HOTH....LFG !!!!!
Sold all on stop .......grrrr Flat trade
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 19, 2024 9:35am
HOTH....LFG !!!!!
$1.50 now
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 19, 2024 9:21am
RE:Hoth ...early a.m runner on NR $1.75
Bigger add to starting position at $1.41 Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 19, 2024 8:29am
RE:Hoth ...early a.m runner on NR $1.75
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ 2024-03-19 05:21 ET - News Release NEW YORK March 19, 2024
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 19, 2024 8:25am
Hoth ...early a.m runner on NR $1.75
I'm in small
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 13, 2024 11:45am
New Press Release - Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024
NEW YORK, Feb. 13, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to attend the BIO CEO and Investor Conference in New York, NY. To learn more about BIO CEO and Investor Conference...
read article.
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon